Involvement of Sphingosine 1-Phosphate (SIP)/S1P3 Signaling in Cholestasis-Induced Liver Fibrosis
- 1 October 2009
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 175 (4), 1464-1472
- https://doi.org/10.2353/ajpath.2009.090037
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Sphingosine 1-Phosphate Potentiates Human Lung Fibroblast Chemotaxis through the S1P2 ReceptorAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- The vascular S1P gradient—Cellular sources and biological significanceBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Thematic Review Series: Sphingolipids. Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling*Journal of Lipid Research, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- Bone marrow stem cells and liver diseaseGut, 2007
- Sphingosine 1-phosphate induces cyclooxygenase-2 via Ca2+-dependent, but MAPK-independent mechanism in rat vascular smooth muscle cellsLife Sciences, 2007
- Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosisJournal of Hepatology, 2006
- Hepatocyte Growth Factor Attenuates Liver Fibrosis Induced by Bile Duct LigationThe American Journal of Pathology, 2006
- Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured ratsJournal of Hepatology, 2005